CAS: 1252594-99-2 - ETP-46321
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | ETP-46321 REF: TM-TQ0229CAS: 1252594-99-2 | 99.47% | 94.00 €~2,387.00 € | Tue 28 May 24 |
 | ETP-46321 REF: 3D-CAC59499CAS: 1252594-99-2 | Min. 95% | To inquire | Tue 02 Jul 24 |
ETP-46321
CAS:1252594-99-2
ETP-46321 is an effective and orally bioavailable PI3Kα/PI3Kδ inhibitor (Ki: 2.3/14.2 nM).
Formula:
C20H27N9O3S
Purity:
99.47%
Color and Shape:
Solid
Molecular weight:
473.55
Ref: TM-TQ0229
| 1mg | 94.00 € | |
| 5mg | 245.00 € | |
| 10mg | 371.00 € | |
| 25mg | 620.00 € | |
| 50mg | 877.00 € | |
| 100mg | 1,196.00 € | |
| 500mg | 2,387.00 € | |
| 1ml*10 (DMSO) | 268.00 € |
Estimated delivery in United States, on Tuesday 28 May 2024
ETP-46321
CAS:1252594-99-2
ETP-46321 is an imidazopyrazine that inhibits the activity of the enzyme phosphatase 2A, which is …
Formula:
C20H27N9O3S
Purity:
Min. 95%
Molecular weight:
473.55 g/mol
Ref: 3D-CAC59499
| 1mg | To inquire | |
| 5mg | To inquire | |
| 10mg | To inquire | |
| 25mg | To inquire | |
| 50mg | To inquire |
Estimated delivery in United States, on Tuesday 2 Jul 2024
